M. P. Mingeot-Leclercq

670 total citations
15 papers, 518 citations indexed

About

M. P. Mingeot-Leclercq is a scholar working on Molecular Biology, Pharmacology and Molecular Medicine. According to data from OpenAlex, M. P. Mingeot-Leclercq has authored 15 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Pharmacology and 3 papers in Molecular Medicine. Recurrent topics in M. P. Mingeot-Leclercq's work include Lipid Membrane Structure and Behavior (7 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Sphingolipid Metabolism and Signaling (3 papers). M. P. Mingeot-Leclercq is often cited by papers focused on Lipid Membrane Structure and Behavior (7 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Sphingolipid Metabolism and Signaling (3 papers). M. P. Mingeot-Leclercq collaborates with scholars based in Belgium, Greece and United Kingdom. M. P. Mingeot-Leclercq's co-authors include Paul M. Tulkens, Françoise Van Bambeke, Robert Brasseur, Donatienne Tyteca, Yves F. Dufrêne, Cristina Seral, Sandrine Lemaire, Pierre Baudoux, Jocelyne Piret and Alexandre Berquand and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and Physical Chemistry Chemical Physics.

In The Last Decade

M. P. Mingeot-Leclercq

15 papers receiving 497 citations

Peers

Countries citing papers authored by M. P. Mingeot-Leclercq

Since Specialization

Citations

This map shows the geographic impact of M. P. Mingeot-Leclercq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. P. Mingeot-Leclercq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. P. Mingeot-Leclercq more than expected).

Fields of papers citing papers by M. P. Mingeot-Leclercq

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. P. Mingeot-Leclercq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. P. Mingeot-Leclercq. The network helps show where M. P. Mingeot-Leclercq may publish in the future.

Co-authorship network of co-authors of M. P. Mingeot-Leclercq

This figure shows the co-authorship network connecting the top 25 collaborators of M. P. Mingeot-Leclercq. A scholar is included among the top collaborators of M. P. Mingeot-Leclercq based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. P. Mingeot-Leclercq. M. P. Mingeot-Leclercq is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	The molecular mechanism of Nystatin action is dependent on the membrane biophysical properties and lipid composition 2017 ·Physical Chemistry Chemical Physics ·(unknown), Joaquim T. Marquês, (unknown), (unknown), Ana S. Viana, M. P. Mingeot-Leclercq, Rodrigo F.M. de Almeida, Liana C. Silva	38
2	Contribution of plasma membrane lipid domains to red blood cell (re)shaping 2017 ·Scientific Reports ·Catherine Léonard, Louise Conrard, (unknown), Hélène Pollet, (unknown), C. Vermylen, (unknown), Patrick Van Deŕ Smissen, M. P. Mingeot-Leclercq, Donatienne Tyteca	40
3	Evaluation of macrophage cell membrane preparations for proteomics analysis 2007 ·FEBS Journal ·(unknown), Maarten Aerts, M. P. Mingeot-Leclercq, Ruddy Wattiez, (unknown), Bart Devreese, (unknown)	1
4	Decrease of elastic moduli of DOPC bilayers induced by a macrolide antibiotic, azithromycin 2007 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·(unknown), Laurence Lins, (unknown), Yves F. Dufrêne, Patrick Van Deŕ Smissen, Robert Brasseur, Donatienne Tyteca, M. P. Mingeot-Leclercq	59
5	Selection of quinolone resistance in Streptococcus pneumoniae exposed in vitro to subinhibitory drug concentrations 2007 ·Journal of Antimicrobial Chemotherapy ·Laëtitia Avrain, M.I. Garvey, Narcisa Mesaros, Y. Glupczynski, M. P. Mingeot-Leclercq, Laura J. V. Piddock, Paul M. Tulkens, R. Vanhoof, Françoise Van Bambeke	27
6	Combined effect of pH and concentration on the activities of gentamicin and oxacillin against Staphylococcus aureus in pharmacodynamic models of extracellular and intracellular infections 2006 ·Journal of Antimicrobial Chemotherapy ·Pierre Baudoux, (unknown), Sandrine Lemaire, M. P. Mingeot-Leclercq, Paul M. Tulkens, Françoise Van Bambeke	79
7	Interaction of the Macrolide Antibiotic Azithromycin with Lipid Bilayers: Effect on Membrane Organization, Fluidity, and Permeability 2005 ·Pharmaceutical Research ·Alexandre Berquand, (unknown), (unknown), M. P. Mingeot-Leclercq	45
8	Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages 2005 ·Journal of Antimicrobial Chemotherapy ·Cristina Seral, (unknown), M. P. Mingeot-Leclercq, Paul M. Tulkens, Françoise Van Bambeke	65
9	The macrolide antibiotic azithromycin interacts with lipids and affects membrane organization and fluidity: Studies on langmuir-blodgett monolayers, liposomes and J774 macrophages 2003 ·The Journal of Membrane Biology ·Donatienne Tyteca, André Schanck, Yves F. Dufrêne, Magali Deleu, Pierre J. Courtoy, Paul M. Tulkens, M. P. Mingeot-Leclercq	43
10	Interactions of Macrolide Antibiotics (Erythromycin A, Roxithromycin, Erythromycylamine [Dirithromycin], and Azithromycin) with Phospholipids: Computer-Aided Conformational Analysis and Studies on Acellular and Cell Culture Models 1999 ·Toxicology and Applied Pharmacology ·(unknown), Françoise Van Bambeke, Jocelyne Piret, Robert Brasseur, Paul M. Tulkens, M. P. Mingeot-Leclercq	67
11	Synthesis and Antimicrobial and Toxicological Studies of Amino Acid and Peptide Derivatives of Kanamycin A and Netilmicin 1995 ·Journal of Medicinal Chemistry ·(unknown), M. P. Mingeot-Leclercq, Violetta Constantinou‐Kokotou, Robert Brasseur, (unknown), Paul M. Tulkens	20
12	New derivatives of kanamycin B obtained by modifications and substitutions in position 6''. 1. Synthesis and microbiological evaluation 1991 ·Journal of Medicinal Chemistry ·Ann Van Schepdael, (unknown), (unknown), Roger Busson, L. Verbist, H. Vanderhaeghe, M. P. Mingeot-Leclercq, Paul M. Tulkens, P. Claes	13
13	New derivatives of kanamycin B obtained by modifications and substitutions in position 6''. 2. In vitro and computer-aided toxicological evaluation with respect to interactions with phosphatidylinositol 1991 ·Journal of Medicinal Chemistry ·M. P. Mingeot-Leclercq, Ann Van Schepdael, Robert Brasseur, Roger Busson, H. Vanderhaeghe, P. Claes, Paul M. Tulkens	10
14	New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation 1991 ·Journal of Medicinal Chemistry ·Ann Van Schepdael, Roger Busson, H. Vanderhaeghe, P. Claes, L. Verbist, M. P. Mingeot-Leclercq, Robert Brasseur, Paul M. Tulkens	9
15	Use of an In vitro model to assess aminoglycoside-phospholipid interactions in relation to their nephrotoxicity 1986 ·Food and Chemical Toxicology ·Marianne Carlier, Robert Brasseur, G Laurent, M. P. Mingeot-Leclercq, Jean Marie Ruysschaert, Paul M. Tulkens	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact